CoChat
Sign Up
Cited by 40

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Ghrelin reduces TNF-α-induced human hepatocyte apoptosis, autophagy and pyroptosis: role in obesity-associated NAFLD

Ezquerro, Silvia, Mocha, Fátima, Frühbeck, Gema, Guzmán-Ruiz, Rocío, Valentí, Víctor, Mugueta, Carmen, Becerril, Sara, Catalán, Victoria, Gómez-Ambrosi, Javier, Silva, Camilo, Salvador, Javier, Colina, Inmaculada, Malagón, María del Mar, Rodríguez, Amaia·2018·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2018-01171
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2018-01171

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 57

  1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non- alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Associ- ation. Hepatology. 2012;55(6):2005-2023.
  2. European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Associ- ation for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388-1402.
  3. Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE. Nonalcoholic fatty liver disease: evolving para- digms. World J Gastroenterol. 2017;23(36):6571-6592.
  4. Villarejo C, Fern ández-Aranda F, Jiménez-Murcia S, Pe ñas-Lled ó E, Granero R, Penelo E, Tinahones FJ, Sancho C, Vilarrasa N, Montserrat-Gil de Bernabé M, Casanueva FF, Fern ández-Real JM, Fr ühbeck G, De la Torre R, Treasure J, Botella C, Mench ón JM. Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlates. Eur Eat Disord Rev. 2012;20(3):250-254.
  5. Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65(8):1017-1025.
  6. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease- meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.
  7. Machado M, Marqués-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006; 45(4):600-606.
  8. Younossi ZM. The epidemiology of nonalcoholic steatohepatitis. Clin Liver Dis. 2018;11(4):92-94.
  9. Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014;60(5):1063-1074.
  10. Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF- a-induced apoptosis in liver injury. J Cell Mol Med. 2004;8(4):445-454.
  11. Schneider JL, Cuervo AM. Liver autophagy: much more than just taking out the trash. Nat Rev Gastroenterol Hepatol. 2014;11(3): 187-200.
  12. Ezquerro S, Méndez-Giménez L, Becerril S, Moncada R, Valentí V, Catal án V, G ómez-Ambrosi J, Fr ühbeck G, Rodríguez A. Acylated and desacyl ghrelin are associated with hepatic lipogenesis, b-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats. Sci Rep. 2016;6(1):39942.
  13. Gan LT, Van Rooyen DM, Koina ME, McCuskey RS, Teoh NC, Farrell GC. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4- dependent. J Hepatol. 2014;61(6):1376-1384.
  14. Guzm án-Ruiz R, Ortega F, Rodríguez A, V ázquez-Martínez R, Díaz-Ruiz A, García-Navarro S, Giralt M, Garcia-Rios A, Cobo- Padilla D, Tinahones FJ, L ópez-Miranda J, Villarroya F, Fr ühbeck G, Fern ández-Real JM, Malag ón MM. Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in b-cells. Int J Obes. 2014;38(12):1545-1554.
  15. Estep M, Abawi M, Jarrar M, Wang L, Stepanova M, Elariny H, Moazez A, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. Obes Surg. 2011;21(11):1750-1757.
  16. Marchesini G, Pagotto U, Bugianesi E, De Iasio R, Manini R, Vanni E, Pasquali R, Melchionda N, Rizzetto M. Low ghrelin concen- trations in nonalcoholic fatty liver disease are related to insulin resistance. J Clin Endocrinol Metab. 2003;88(12):5674-5679.
  17. Mykhalchyshyn G, Kobyliak N, Bodnar P. Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients. J Diabetes Metab Disord. 2015;14(1): 44.
  18. Rodríguez A, G ómez-Ambrosi J, Catal án V, Becerril S, S áinz N, Gil MJ, Silva C, Salvador J, Barba J, Colina I, Fr ühbeck G. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens. 2010; 28(3):560-567.
  19. Fr ühbeck G, Diez Caballero A, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med. 2004; 350(3):308-309.
  20. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279(3):909-913.
  21. M üller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, Batterham RL, Benoit SC, Bowers CY, Broglio F, Casanueva FF, D'Alessio D, Depoortere I, Geliebter A, Ghigo E, Cole PA, Cowley M, Cummings DE, Dagher A, Diano S, Dickson SL, Diéguez C, Granata R, Grill HJ, Grove K, Habegger KM, Heppner K, Heiman ML, Holsen L, Holst B, Inui A, Jansson JO, Kirchner H, Korbonits M, Laferrère B, LeRoux CW, Lopez M, Morin S, Nakazato M, Nass R, Perez-Tilve D, Pfluger PT, Schwartz TW, Seeley RJ, Sleeman M, Sun Y, Sussel L, Tong J, Thorner MO, van der Lely AJ, van der Ploeg LH, Zigman JM, Kojima M, Kangawa K, Smith RG, Horvath T, Tsch öp MH. Ghrelin. Mol Metab. 2015;4(6):437-460.
  22. Italian Association for the Study of the Liver (AISF). AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions. Dig Liver Dis. 2017;49(5):471-483.
  23. Rodríguez A, G ómez-Ambrosi J, Catal án V, Gil MJ, Becerril S, S áinz N, Silva C, Salvador J, Colina I, Fr ühbeck G. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes. 2009;33(5):541-552.
  24. Baragli A, Ghe C, Arnoletti E, Granata R, Ghigo E, Muccioli G. Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase g and phosphodiesterase 3B. Biochim Biophys Acta. 2011;1811(6):386-396.
  25. Sangiao-Alvarellos S, V ázquez MJ, Varela L, Nogueiras R, Saha AK, Cordido F, L ópez M, Diéguez C. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology. 2009;150(10):4562-4574.
  26. Porteiro B, Díaz-Ruíz A, Martínez G, Senra A, Vidal A, Serrano M, Gualillo O, L ópez M, Malag ón MM, Diéguez C, Nogueiras R. Ghrelin requires p53 to stimulate lipid storage in fat and liver. Endocrinology. 2013;154(10):3671-3679.
  27. Barazzoni R, Semolic A, Cattin MR, Zanetti M, Guarnieri G. Acylated ghrelin limits fat accumulation and improves redox state and inflammation markers in the liver of high-fat-fed rats. Obesity (Silver Spring). 2014;22(1):170-177.
  28. Rodríguez A, G ómez-Ambrosi J, Catal án V, Rotellar F, Valentí V, Silva C, Mugueta C, Pulido MR, V ázquez R, Salvador J, Malag ón MM, Colina I, Fr ühbeck G. The ghrelin O-acyltransferase-ghrelin system reduces TNF-a-induced apoptosis and autophagy in human visceral adipocytes. Diabetologia. 2012;55(11):3038-3050.
  29. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004; 24(1):3-20.
  30. Catal án V, G ómez-Ambrosi J, Rotellar F, Silva C, Gil MJ, Rodríguez A, Cienfuegos JA, Salvador J, Fr ühbeck G. The obe- statin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2007;66(4):598-601.
  31. Rodríguez A, Catal án V, G ómez-Ambrosi J, García-Navarro S, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador J, Burrell MA, Calamita G, Malag ón MM, Fr ühbeck G. Insulin-and leptin- mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. J Clin Endocrinol Metab. 2011;96(4):E586-E597.
  32. Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Targher G, Lonardo A. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases. Metabolism. 2017;72:57-65.
  33. Ezquerro S, Fr ühbeck G, Rodríguez A. Ghrelin and autophagy. Curr Opin Clin Nutr Metab Care. 2017;20(5):402-408.
  34. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A. The nuclear protein HMGB1 is secreted by mono- cytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002;3(10):995-1001.
  35. Younossi ZM, Stepanova M, Rafiq N, Makhlouf H, Younoszai Z, Agrawal R, Goodman Z. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver- related mortality. Hepatology. 2011;53(6):1874-1882.
  36. Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 2017;34(6):1291-1326.
  37. Fr ühbeck G. Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nat Rev Endocrinol. 2015;11(8):465-477.
  38. Lassailly G, Caïazzo R, Pattou F, Mathurin P. Bariatric surgery for curing NASH in the morbidly obese? J Hepatol. 2013;58(6): 1249-1251.
  39. Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532-540.
  40. Taitano AA, Markow M, Finan JE, Wheeler DE, Gonzalvo JP, Murr MM. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429-436.
  41. Uribe M, Zamora-Valdés D, Moreno-Portillo M, Bermejo- Martínez L, Pichardo-Bahena R, Baptista-González HA, Ponciano- Rodríguez G, Uribe MH, Medina-Santillán R, Méndez-Sánchez N. Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease. Ann Hepatol. 2008;7(1): 67-71.
  42. Barazzoni R, Zanetti M, Nagliati C, Cattin MR, Ferreira C, Giuricin M, Palmisano S, Edalucci E, Dore F, Guarnieri G, de Manzini N. Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction. Obesity (Silver Spring). 2013;21(4):718-722.
  43. Crespo J, Cay ón A, Fern ández-Gil P, Hern ández-Guerra M, Mayorga M, Domínguez-Díez A, Fern ández-Escalante JC, Pons- Romero F. Gene expression of tumor necrosis factor a and TNF- receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001;34(6):1158-1163.
  44. Mao Y, Wang J, Yu F, Li Z, Li H, Guo C, Fan X. Ghrelin protects against palmitic acid or lipopolysaccharide-induced hepatocyte apoptosis through inhibition of MAPKs/iNOS and restoration of Akt/eNOS pathways. Biomed Pharmacother. 2016;84:305-313.
  45. Mao Y, Cheng J, Yu F, Li H, Guo C, Fan X. Ghrelin attenuated lipotoxicity via autophagy induction and nuclear factor-kB in- hibition. Cell Physiol Biochem. 2015;37(2):563-576.
  46. Granado M, Martín AI, L ópez-Mendui ña M, L ópez-Calder ón A, Villan úa MA. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. Am J Physiol Endocrinol Metab. 2008;294(1):E131-E141.
  47. Chang E, Kim L, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY. Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. World J Gastroenterol. 2015; 21(25):7754-7763.
  48. Gonz ález-Rodríguez A, Mayoral R, Agra N, Valdecantos MP, Pardo V, Miquilena-Colina ME, Vargas-Castrill ón J, Lo Iacono O, Corazzari M, Fimia GM, Piacentini M, Muntané J, Bosc á L, García-Monz ón C, Martín-Sanz P, Valverde AM. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis. 2014; 5(4):e1179.
  49. Liu HY, Han J, Cao SY, Hong T, Zhuo D, Shi J, Liu Z, Cao W. Hepatic autophagy is suppressed in the presence of insulin re- sistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem. 2009;284(45):31484-31492.
  50. Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol. 2013;59(3):583-594.
  51. Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Broglio F, Ross RJ, Ghigo E, van der Lely AJ. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab. 2005;90(2):1055-1060.
  52. Geng Y, Ma Q, Liu YN, Peng N, Yuan FF, Li XG, Li M, Wu YS, Li BL, Song WB, Zhu W, Xu WW, Fan J, Su L. Heatstroke induces liver injury via IL-1b and HMGB1-induced pyroptosis. J Hepatol. 2015;63(3):622-633.
  53. Chen M, Huang W, Wang C, Nie H, Li G, Sun T, Yang F, Zhang Y, Shu K, Wang C, Gong Q. High-mobility group box 1 exacerbates CCl 4 -induced acute liver injury in mice. Clin Immunol. 2014; 153(1):56-63.
  54. Yang H, Wang H, Wang Y, Addorisio M, Li J, Postiglione MJ, Chavan SS, Al-Abed Y, Antoine DJ, Andersson U, Tracey KJ. The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation. J Intern Med. 2017;282(1):76-93.
  55. Horiuchi T, Sakata N, Narumi Y, Kimura T, Hayashi T, Nagano K, Liu K, Nishibori M, Tsukita S, Yamada T, Katagiri H, Shirakawa R, Horiuchi H. Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity. J Biol Chem. 2017;292(20):8436-8446.
  56. Chorny A, Anderson P, Gonzalez-Rey E, Delgado M. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J Immunol. 2008; 180(12):8369-8377.
  57. Sun N, Wang H, Wang L. Protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase and inflammation in a mouse model of myocardial ischemia/reperfusion injury via the HMGB1 and TLR4/NF-kB pathway. Mol Med Rep. 2016;14(3): 2764-2770.

Cited by

Sorted by citations

Metadata

Authors
Ezquerro, S., Mocha, F., Frühbeck, G., Guzmán-Ruiz, R., Valentí, V., Mugueta, C., Becerril, S., Catalán, V., Gómez-Ambrosi, J., Silva, C., Salvador, J., Colina, I., Malagón, M. D. M., & Rodríguez, A.
Affiliations
  • Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain
  • Department of Cell Biology, Physiology, and Immunology, Instituto Maimónides de Investigación Biomédica (IMIBIC)/University of Córdoba/Reina Sofía University Hospital, Córdoba, Spain
  • Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain
  • Department of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain
  • Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain
  • Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2018-08-20
ISSN
  • 0021-972X
  • 1945-7197
DOI
10.1210/jc.2018-01171
Cited by
40
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review